<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="and has evidence of a synergistic in vitro effect with" exact="ribavirin" post="[[57], [58], [59]]; has been used for years as"/>
 <result pre="it may interfere with the dosage of anticoagulants such as" exact="ribavirin" post="[56]. Moreover, it may also interact with HMG-CoA reductase"/>
 <result pre="no cytotoxicity or adverse reactions related [[51], [52], [53], [54]]." exact="Ribavirin" post="that binds to the active site on RdRp has"/>
 <result pre="of the active metabolites of and increased serum concentrations [56]." exact="Hydroxychloroquine" post="(HCQ) was originally developed and used for the treatment"/>
 <result pre="[69], [70]], a French study evaluated 26 patients treated with" exact="hydroxychloroquine" post="and 16 control patients, all positive for the virus"/>
 <result pre="showed that the effect of the drug was enhanced by" exact="azithromycin" post="[71]. The experimental protocol included 200 mg of oral"/>
 <result pre="azithromycin [71]. The experimental protocol included 200 mg of oral" exact="hydroxychloroquine" post="sulfate, three times a day for ten days in"/>
 <result pre="based on clinical judgment. The authors documented the efficacy of" exact="hydroxychloroquine" post="in reducing the viral load at day 7. Although"/>
 <result pre="rule out a cardiotoxic effect. Recent studies have shown that" exact="azithromycin" post="(AZM), and the closely related drug roxithromycin, both act"/>
 <result pre="replication of other viruses, such as Ebola and HIV-1 [69,80,81]." exact="Azithromycin" post="has been linked to an increased risk of ventricular"/>
 <result pre="that the risk of ventricular arrhythmia with the use of" exact="azithromycin" post="is likely to be due to the patient's health"/>
 <result pre="without symptoms of hepatic impairmentTher. Drug Monit.36April (2)201419220110.1097/FTD.0b013e3182a28c6a24632753 56MueckW.KubitzaD.BeckaM.Co-administration of" exact="rivaroxaban" post="with drugs that share its elimination pathways: pharmacokinetic effects"/>
 <result pre="A ReviewJAMA13202010.1001/jama.2020.6019Apr 61MorganR.E.CampbellS.E.SuehiraK.SponsellerC.A.YuC.Y.MedlockM.M.Effects of steady-state lopinavir/ritonavir on the pharmacokinetics of" exact="pitavastatin" post="in healthy adult volunteersJ. Acquir. Immune Defic. Syndr.60Junuary1(2)201215816410.1097/QAI.0b013e318251addb22627182 62AlarcÃ³nG.S.McGwinG.BertoliA.M.FesslerB.J.Calvo-AlÃ©nJ.BastianH.M.VilÃ¡L.M.ReveilleJ.D.LUMINA"/>
 <result pre="adult volunteersJ. Acquir. Immune Defic. Syndr.60Junuary1(2)201215816410.1097/QAI.0b013e318251addb22627182 62AlarcÃ³nG.S.McGwinG.BertoliA.M.FesslerB.J.Calvo-AlÃ©nJ.BastianH.M.VilÃ¡L.M.ReveilleJ.D.LUMINA Study GroupEffect of" exact="hydroxychloroquine" post="on the survival of patients with systemic lupus erythematosus:"/>
 <result pre="multiethnic US cohort (LUMINA L)Ann. Rheum. Dis.6620071168117217389655 63WillisR.SeifA.M.Jr McGwinG.Martinez-MartinezL.A.GonzÃ¡lezE.B.DangN.PapalardoE.LiuJ.VilÃ¡L.M.ReveilleJ.D.AlarcÃ³nG.S.PierangeliS.S.Effect of" exact="hydroxychloroquine" post="treatment on pro-inflammatory cytokines and disease activity in SLE"/>
 <result pre="Plasmodium in reticulocytes can occur without hemozoin formation, resulting in" exact="chloroquine" post="resistanceJ. Exp. Med.212June 1 (6)201589390310.1084/jem.2014173125941254 67TÃ¶nnesmannE.KandolfR.LewalterT.Chloroquine cardiomyopathy - a"/>
 <result pre="cardiomyopathy - a review of the literatureImmunopharmacol. Immunotoxicol.35June (3)201343444210.3109/08923973.2013.78007823635029 68GaoJ.TianZ.YangX.Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
 <result pre="coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis.9202010.1093/cid/ciaa237Mar pii: ciaa237 71GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.DupontH.T.HonorÃ©S.ColsonP.ChabriÃ¨reE.La ScolaB.RolainJ.M.BrouquiP.RaoultD.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="an open-label non-randomized clinical trialInt. J. Antimicrob. Agents20202010594910.1016/j.ijantimicag.2020.105949Mar 72PetriM.Use of" exact="hydroxychloroquine" post="to prevent thrombosis in systemic lupus erythematosus and in"/>
 <result pre="73WhiteN.J.Cardiotoxicity of antimalarial drugsLancet Infect. Dis.7200754955817646028 74WozniackaA.CygankiewiczI.ChudzickM.The cardiac safety of" exact="chloroquine" post="phosphate treatment in patients with systemic lupus erythematosus: the"/>
 <result pre="in systemic lupus erythematosusClin. Exp. Rheumatol.36July-August (4)201854555129652656 76CairoliE.DaneseN.TelizM.BruzzoneM.J.FerreiraJ.RebellaM.CayotaA.Cumulative dose of" exact="hydroxychloroquine" post="is associated with a decrease of resting heart rate"/>
 <result pre="patients with systemic lupus erythematosus: a pilot studyLupus2420151204120910.1177/096120331558087025852050 77OzsvariB.NuttallJ.R.SotgiaF.LisantiM.P.Azithromycin and" exact="Roxithromycin" post="define a new family of &quot;senolytic&quot; drugs that target"/>
 <result pre="(Albany NY)1020183294330710.18632/aging.10163330428454 78AvedissianS.N.RhodesN.J.NgT.N.H.RaoA.P.BeringerP.M.The potential for QT interval prolongation with chronic" exact="azithromycin" post="therapy in adult cystic fibrosis patientsPharmacotherapy39201971872310.1002/phar.227031045258 79TangF.LiR.XueJ.LanJ.XuH.LiuY.ZhouL.LuY.Azithromycin attenuates acute"/>
 <result pre="inhibitors for drug repurposingACS Infect. Dis.1July 10 (7)201531732610.1021/acsinfecdis.5b0003027622822 81RoyJ.PaquetteJ.S.FortinJ.F.TremblayM.J.The immunosuppressant" exact="rapamycin" post="represses human immunodeficiency virus type 1 replicationAntimicrob. Agents Chemother.46November(11)20023447345512384349"/>
 <result pre="azithromycinCardiovasc. Toxicol.17October (4)201743444010.1007/s12012-017-9401-728213753 83LeeR.A.GuytonA.KunzD.CutterG.R.HoesleyC.J.Evaluation of baseline corrected QT interval and" exact="azithromycin" post="prescriptions in an academic medical centerJ. Hosp. Med.11January (1)2016152010.1002/jhm.244826287278"/>
 <result pre="(1)2016152010.1002/jhm.244826287278 84PatelH.CalipG.S.Di DomenicoR.J.SchumockG.T.SudaK.J.LeeT.A.Prevalence of cardiac risk factors in patients prescribed" exact="azithromycin" post="before and after the 2012 FDA warning on the"/>
 <result pre="heart rhythmsPharmacotherapy40202010711510.1002/phar.235531867748 85AvedissianS.N.RhodesN.J.NgT.N.M.RaoA.P.BeringerP.M.The potential for QT interval prolongation with chronic" exact="azithromycin" post="therapy in adult cystic fibrosis patientsPharmacotherapy39201971872310.1002/phar.227031045258 86FangL.KarakiulakisG.RothM.Are patients with"/>
 <result pre="Respir. Med.6September (9)201869169810.1016/S2213-2600(18)30177-230078618 94McAuleyD.F.LaffeyJ.G.Oâ€™KaneC.M.PerkinsG.D.MullanB.TrinderT.J.JohnstonP.HopkinsP.A.JohnstonA.J.McDowellC.McNally; HARP-2C.Investigators; Irish Critical Care Trials Group." exact="Simvastatin" post="in the acute respiratory distress syndromeN. Engl. J. Med.371October"/>
</results>
